−0.9291 USD
−80.65 M USD
0.00 USD
77.15 M
About Renovaro Inc.
Sector
Industry
CEO
David Weinstein
Website
Headquarters
Los Angeles
Founded
2011
FIGI
BBG0060CNMG8
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RENB is 0.8706 USD — it has increased by 1.17% in the past 24 hours. Watch Renovaro Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Renovaro Inc. stocks are traded under the ticker RENB.
RENB stock has fallen by −43.43% compared to the previous week, the month change is a 42.74% rise, over the last year Renovaro Inc. has showed a −72.79% decrease.
RENB reached its all-time high on Dec 1, 2021 with the price of 13.7799 USD, and its all-time low was 0.3928 USD and was reached on Jun 29, 2023. View more price dynamics on RENB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RENB stock is 27.56% volatile and has beta coefficient of 2.32. Track Renovaro Inc. stock price on the chart and check out the list of the most volatile stocks — is Renovaro Inc. there?
Today Renovaro Inc. has the market capitalization of 145.56 M, it has decreased by −38.69% over the last week.
Yes, you can track Renovaro Inc. financials in yearly and quarterly reports right on TradingView.
RENB net income for the last quarter is −44.21 M USD, while the quarter before that showed −15.73 M USD of net income which accounts for −181.04% change. Track more Renovaro Inc. financial stats to get the full picture.
No, RENB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 25.00 employees. See our rating of the largest employees — is Renovaro Inc. on this list?
Like other stocks, RENB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Renovaro Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Renovaro Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Renovaro Inc. stock shows the sell signal. See more of Renovaro Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.